12
Participants
Start Date
March 20, 2007
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
Motavizumab
A single IM dose of 30 mg/kg will be administered on Day 0 of the study.
Placebo
A single IM dose of placebo matched to motavizumab will be administered on Day 0 of the study.
Research Site, Richmond
West Virginia University Pediactric Center, Charleston
Research Site, Morgantown
Research Site, Atlanta
Research Site, Augusta
Research Site, Tampa
Research Site, Youngstown
Research Site, Detroit
Research Site, Little Rock
Research Site, Charleston
Research Site, Jonesboro
Research Site, Oklahoma City
Research Site, Dallas
Research Site, Dallas
Research Site, Houston
Research Site, Las Vegas
Research Site, San Diego
Research Site, Orange
Research Site, Tucson
Research Site, Jonesboro
Research Site, Little Rock
Research Site, Miami
Research Site, Chicago
Research Site, Baltimore
Research Site, The Bronx
Research Site, Boston
Research Site, Paterson
Research Site, Brooklyn
Research Site, Buffalo
Research Site, Nashville
Research Site, Huntington
Lead Sponsor
MedImmune LLC
INDUSTRY